Mochtar MH

No ORCID on file · 6 papers in corpus · active 2014-2021

Condition tags

  • infertility 1
2021
Birthweight and other perinatal outcomes of singletons conceived after assisted reproduction compared to natural conceived singletons in couples with unexplained subfertility: follow-up of two randomized clinical trials.
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deaa298

Study questionDoes assisted reproduction, such as ovarian stimulation and/or laboratory procedures, have impact on perinatal outcomes of singleton live births compared to natural conception in couples with unexplained subfertility?Summary a…

2019
Cumulative live birth rates in low-prognosis women.
Human reproduction (Oxford, England) ·doi:10.1093/humrep/dez051

Study questionDo cumulative live birth rates (CLBRs) over multiple IVF/ICSI cycles confirm the low prognosis in women stratified according to the POSEIDON criteria?Summary answerThe CLBR of low-prognosis women is ~56% over 18 months of IVF/…

2019
Interventions for unexplained infertility: a systematic review and network meta-analysis.
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd012692.pub2

BackgroundClinical management for unexplained infertility includes expectant management as well as active treatments, including ovarian stimulation (OS), intrauterine insemination (IUI), OS-IUI,  and in vitro fertilisation (IVF) with or wit…

2018
Intrauterine insemination versus intracervical insemination in donor sperm treatment.
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd000317.pub4

BackgroundThe first-line treatment in donor sperm treatment consists of inseminations that can be done by intrauterine insemination (IUI) or by intracervical insemination (ICI).ObjectivesTo compare the effectiveness and safety of intrauteri…

2017
Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles.
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd005070.pub3

BackgroundOne of the various ovarian stimulation regimens used for in-vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycles is the use of recombinant follicle-stimulating hormone (rFSH) in combination with a gonadotrop…

2014
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd008046.pub4

BackgroundHuman chorionic gonadotropin (HCG) is routinely used for final oocyte maturation triggering in in vitro fertilisation (IVF)/intracytoplasmic sperm injection (ICSI) cycles, but the use of HCG for this purpose may have drawbacks. Go…